银杏叶治疗心绞痛的网络药理学研究

doi:10.19803/j.1672-8629.2022.02.10

摘要/Abstract

摘要： 目的采用网络药理学方法研究银杏叶治疗心绞痛(angina pectoris,AP)的生物机制。方法从中药系统药理学分析平台(TCMSP)筛选银杏叶的化学活性成分,收集作用靶标;采用CTD、TTD、Drugbank、OMIM和GeneCards数据库检索AP相关靶点。采用Cytoscape软件构建成分-靶点-疾病网络图,利用STRING数据库构建靶蛋白相互作用网络图,并对相关靶点进行GO功能富集分析、KEGG信号通路分析。结果筛选后获得银杏叶有效成分30个,治疗AP的潜在靶点基因111个。有效成分槲皮素、山柰素、阿魏酸等,主要作用于PIK3CG、MAPK14、NOS3、AKT1等关键靶点,通过流体剪切应力动脉粥样硬化、PI3K-Akt、MAPK、钙信号通路等通路,发挥抗炎、抗氧化、抗凋亡、调节离子通道等功能治疗AP。结论利用中药“多成分-多靶点-多通路”的特点,探究银杏叶治疗AP的潜在作用机制,为银杏叶治疗AP以至扩大适应证的后续科学研究及临床应用提供了一定参考。

关键词: 银杏叶, 心绞痛, 网络药理学, 蛋白相互作用, 富集分析

Abstract: Objective To explore the biological mechanism by which Ginkgo Biloba protects against angina pectoris（AP）using network pharmacology. Methods The chemical active ingredients of Ginkgo Biloba leaves were screened from the Traditional Chinese Medicine System Pharmacology Analysis Platform (TCMSP) and the targets were collected. Such databases as TTD, TTTD, Drugbank, OMIM and GeneCards were searched for AP-related targets. A component-target-disease network was constructed with Cytoscape software. The protein-protein interaction (PPI) network was analyzed using STRING database. GO enrichment analysis and KEGG signal pathway analysis were performed on related targets. Results After selection, 30 active components of Ginkgo Biloba leaves and 111 potential target genes for AP were obtained. The active ingredients, such as quercetin, kaanide and ferulic acid, mainly acted on PIK3CG, MAPK14, NOS3, Akt1 and other key targets. Through fluid shear stress, PI3K-Akt, MAPK, calcium signaling pathway and other signaling pathways, these active ingredients protected against angina pectoris by means of anti-inflammation, anti-oxidation, anti-apoptosis, and regulation of ion channels. Conclusion The potential mechanism of Ginkgo Biloba for AP has been explored based on the multi-component, multi-target, and multi-pathway characteristics of traditional Chinese medicine, which can facilitate subsequent research and clinical application of Ginkgo Biloba in the treatment of AP and extended indications.

Key words: Ginkgo Biloba, angina pectoris, network pharmacology, protein-protein interaction, enrichment analysis

中图分类号:

R285R966

张强, 杜鹏程, 满春蕊, 孙倩. 银杏叶治疗心绞痛的网络药理学研究[J]. 中国药物警戒, 2022, 19(2): 158-163.

ZHANG Qiang, DU Pengcheng, MAN Chunrui, SUN Qian. Network pharmacology of protection against angina pectoris by Ginkgo Biloba[J]. Chinese Journal of Pharmacovigilance, 2022, 19(2): 158-163.

参考文献

[1] WANG MY, WU W, YU F, et al.Pharmaceutical care of patients with coronary heart disease after gastric cancer operation using cardiotoxic chemotherapeutic drugs[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2019, 16(12): 747-749.
[2] ZHANG DD, LIU H, CHEN JY, et al.Bayesian network meta-analysis of randomized controlled trials comparing fufangdanshen dripping pills, isosorbide nitrate and isosorbide mononitrate in treating coronary heart disease angina[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018, 15(7): 419-428, 433.
[3] WU D, ZHANG QJ. Current status and progress of diagnosis and treatment of coronary heart disease in China[J].China Research Hospital(中国研究型医院), 2020, 7(1): 71-75, 192-197.
[4] WANG CA, WEN XH, DING FF.Research progress of ginkgo biloba[J]. Gansu Science and Technology Frontiers(甘肃科技纵横), 2020, 49(12): 64-67,35.
[5] YUAN T, CUI LL, WANG Y, et al.Recent progress in network pharma-cology of traditional Chinese medicine[J]. Acta Chinese Medicine and Pharmacology(中药药学报), 2021(1): 101-106.
[6] WANG X, YU S, JIA Q, et al.Niaoduqing granules relieve chronic kidney disease symptoms by decreasing renal fibrosis and anemia[J].Oncotarget. 2017, 8(34): 55920-55937.
[7] Chinese Society of Traditional Chinese Medicine Cardiovascular disease Branch. Coronary heart disease stable angina pectoris diagnosis and treatment expert consensus[J]. Journal of Traditional Chinese Medicine(中医杂志), 2018, 59(5): 447-450.
[8] ZHAO J, ZUO L, YAO CL, et al.Relationship between serum homocysteine level and oxidative stress in patients with coronary heart disease[J]. Journal of Modern Laboratory Medicine(现代检验医学杂志), 2016, 31(5): 27-29.
[9] TAO ZM, WANG DP, ZHANG SZ, et al.Effects of hedan tablets on the levels of blood lipid inflammatory factors and oxidative stress in patients with coronary heart disease complicated with type 2 diabetes[J]. Chinese Pharmacy(中国药房), 2017, 28(23): 3244-3247.
[10] XIANG DC, ZENG DY, HUO Y.The diagnosis and treatment of coronary spasm syndrome have been recognized by Chinese experts[J]. Chinese Journal of Interventional Cardiology(中国介入心脏病学杂志), 2015, 23(4): 181-186.
[11] SONG GS.Clinical efficacy and safety of ginkgo biloba injection in the treatment of angina pectoris caused by coronary heart disease[J]. Contemporary Chinese Medicine(中国当代医药), 2013, 20(7): 66-67.
[12] LI YP, ZHANG LH, WU HY, et al.Research progress of ginkgo biloba leaf efficacy group and its efficacy[J]. Food Research and Development(食品研究与开发), 2020, 41(15): 182-187.
[13] MA N, LI YJ, FAN JP.Research progress on pharmacological action of quercetin[J].Journal of Liaoning University of Chinese Medicine(辽宁中医药大学学报), 2018, 20(8): 221-224.
[14] CHEKALINA NI, SHUT SV, TRYBRAT TA, et al.Effect of quercetin on parameters of central hemodynamicsand myocardial ischemia in patients with stable coronary heart disease[J]. Wiadomosci Lekarskie, 2017, 70(4): 707-711.
[15] CALDERÓN JM, BURGOS ME, PÉRE GC, et al.A review on the dietary flavonoid kaempferol[J]. Mini Rev Med Chem, 2011, 11(4): 298-344.
[16] DING XJ, ZHENG LL, YANG B, et al.Luteolin attenuates atherosclerosis via modulating signal transducer and activator of transcription 3-mediated inflammatory response[J]. Drug Design, Development and Therapy, 2019, 13(4): 3899-3911.
[17] LYU L, YAO YC, ZHAO G, et al.Rutin inhibits coronary heart disease through ERK1/2 and Akt signaling in a porcine model[J]. Experimental and Therapeutic Medicine, 2018, 15(1): 156-163.
[18] CHEN HW.Clinical view of sodium ferulate injection in the treatment of senile unstable angina pectoris[J]. China Practical Medical(中国实用医药), 2012, 7(13): 184-185.
[19] FÖRSTERMANN U, SESSA WC. Nitric oxide synthases: regulation and function[J]. European Heart Journal, 2012, 33(7): 829-837.
[20] JEONG S, KIM BG, KIM DY, et al.Cannabidiol overcomesoxaliplatin resistance by enhancing NOS3- and SOD2-induced autophagy in human colorectal cancer cells[J]. Cancers, 2019, 11(6): 781-788.
[21] GRECO R, DEMARTINI C, ZANABONI AM, et al.Endothelial nitric oxide synthase inhibition triggers inflammatory responses in the brain of male rats exposed to ischemia-reperfusion injury[J]. Journal of Neuroscience Research, 2018, 96(1): 151-159.
[22] LIU HS, ZHANG J, GUO JL, et al.Phosphoinositide 3- kinase inhibitor LY294002 ameliorates the severity of myosin-induced myocarditis in mice[J]. Curr Res Transl Med, 2016, 64(1) : 21-27.
[23] WANG KL, YU ZK, ZHANG YX, et al.Effect of Huxinkang tablets on MAPK signal pathway in atherosclerosis rats[J]. Guiding JournaL of TCM(中医药导报), 2019, 25(21): 37-39.
[24] ZHANG XX, GU YT, HUANGWL, et al. MicroRNAs targeting MAPK signaling pathways regulate lipogenic cell differentiation[J].Acta Veterin-aria et Zootechnica Sinica(畜牧兽医学报), 2016, 47(11): 2159-2166.
[25] ZHONG WM, JIN X, ZHENG MY, et al.L-glutamine inhibited allergic contact dermatitis through the p38 MAPK/cPLA2 signaling pathway[J]. Medical Journal of Yanbian University, 2017, 40(2): 79-82.
[26] ZHANG GY, ZHUANG ZL, YANG JB.Effects of serum amyloid A on invasion, migration and MAPK signaling pathway of osteosarcoma cells[J]. Chin J Pathophysiol(中国病理生理杂志), 2018, 34(11): 2011-2016.
[27] SCHOTT JJ, ALSHINAWI C, KYNDT F, et al.Cardiac conduction defects associate with mutations in SCN5A[J]. Nature Genetics, 1999, 23(1): 20-21.